CHROMOCELL THERAPEUTICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.25 USD | -1.57% |
|
-8.08% | 0.00% |
| Jun. 24 | Chromocell Therapeutics Corporation(NYSEAM:CHRO) added to S&P TMI Index | CI |
| May. 15 | Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Chromocell Therapeutics Corporation
Price target over the last 5 years
History of analyst recommendation changes
464.YhADB9aEBYyWEHi03-A43jsuo7Fk41fR1EItfa2g8nI.A1p6ZKewPOTDV0j36dZtnA5n-vBX0wiChjZgS5vsrS0jWjVgjNJ336QhDw~e1f99a2fa2f021b9507cb06bddd6c8d1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.25
USD
Average target price
8.5
USD
Spread / Average Target
+580.00%
High Price Target
8.5
USD
Spread / Highest target
+580.00%
Low Price Target
8.5
USD
Spread / Lowest Target
+580.00%
Consensus detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- CHRO Stock
- Consensus Chromocell Therapeutics Corporation
